社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
yeun88
IP属地：未知
+关注
帖子 · 14
帖子 · 14
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
yeun88
yeun88
·
2021-04-30
Hrm
非常抱歉，此主贴已删除
看
655
回复
评论
点赞
2
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-30
Pls like & comment
非常抱歉，此主贴已删除
看
768
回复
2
点赞
6
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-30
Pls comment & like
非常抱歉，此主贴已删除
看
506
回复
2
点赞
2
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-28
Pls comment and like
Google Shares Rise On Revenue And Earnings Beat, $50B Buyback
Google parent company Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL) reported first-quarter earnings Tuesday afternoon.
Google Shares Rise On Revenue And Earnings Beat, $50B Buyback
看
382
回复
7
点赞
6
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-28
Pls comment & like
Google Shares Rise On Revenue And Earnings Beat, $50B Buyback
Google parent company Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL) reported first-quarter earnings Tuesday afternoon.
Google Shares Rise On Revenue And Earnings Beat, $50B Buyback
看
492
回复
4
点赞
4
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-26
Pls comment and like me
非常抱歉，此主贴已删除
看
575
回复
5
点赞
2
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-26
Pls like and comment me
非常抱歉，此主贴已删除
看
586
回复
1
点赞
2
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-25
Ok
MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing
MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting
MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing
看
639
回复
评论
点赞
2
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-25
Hi
MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing
MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting
MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing
看
660
回复
1
点赞
点赞
编组 21备份 2
分享
举报
yeun88
yeun88
·
2021-04-25
Pls like & give me comment
MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing
MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting
MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing
看
446
回复
1
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3582013492527536","uuid":"3582013492527536","gmtCreate":1618919468755,"gmtModify":1618919468755,"name":"yeun88","pinyin":"yeun88","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":12,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.04","exceedPercentage":"60.27%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":1,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":103331474,"gmtCreate":1619746937298,"gmtModify":1634210217856,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Hrm","listText":"Hrm","text":"Hrm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/103331474","repostId":"2131534297","repostType":4,"isVote":1,"tweetType":1,"viewCount":655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103333490,"gmtCreate":1619746890910,"gmtModify":1634210218545,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Pls like & comment ","listText":"Pls like & comment ","text":"Pls like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/103333490","repostId":"1153490597","repostType":4,"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103339386,"gmtCreate":1619746781745,"gmtModify":1634210219490,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Pls comment & like","listText":"Pls comment & like","text":"Pls comment & like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/103339386","repostId":"2131534297","repostType":4,"isVote":1,"tweetType":1,"viewCount":506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":100024762,"gmtCreate":1619570403556,"gmtModify":1634211706000,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Pls comment and like ","listText":"Pls comment and like ","text":"Pls comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/100024762","repostId":"2130373930","repostType":4,"repost":{"id":"2130373930","kind":"highlight","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619556617,"share":"https://www.laohu8.com/m/news/2130373930?lang=&edition=full","pubTime":"2021-04-28 04:50","market":"hk","language":"en","title":"Google Shares Rise On Revenue And Earnings Beat, $50B Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2130373930","media":"Tiger Newspress","summary":"Google parent company Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL) reported first-quarter earnings Tuesday afternoon.","content":"<p>Google parent company <b>Alphabet Inc </b>(NASDAQ:GOOG)(NASDAQ:GOOGL) reported first-quarter earnings Tuesday afternoon.</p><p><b>First Quarter Earnings: </b>Alphabet reported revenue of $55.3 billion in the first quarter, beating estimates of $51.7 billion. The total was up 32% year-over-year.</p><p>Earnings per share of $26.29 beat estimates of $15.88. The company reported net income of $17.9 billion, more than doubling last year’s first-quarter total of $6.8 billion.<img src=\"https://static.tigerbbs.com/04c18e5c94d3b6d4047c6f7b1f4540eb\" tg-width=\"1602\" tg-height=\"670\" referrerpolicy=\"no-referrer\">Total advertising revenue was $44.7 billion in the first quarter, up from the comparable $33.8 billion in the last fiscal year. The company reported search revenue of $31.9 billion, YouTube revenue of $6 billion and Google network revenue of $6.8 billion.</p><p>Google's Cloud revenue improved 46% to $4 billion, though the division lags behind rivals Amazon.com Inc.</p><p>The company’s other segment revenue was $6.5 billion and Google Cloud revenue was $4 billion in the first quarter.<img src=\"https://static.tigerbbs.com/9ed7cd2419e150521d3b20d080a0ba44\" tg-width=\"1614\" tg-height=\"742\" referrerpolicy=\"no-referrer\">Sundar Pichai, CEO of Google and Alphabet, said: “Over the last year, people have turned to Google Search andmany online services to stay informed, connected and entertained. We’ve continued our focus on delivering trustedservices to help people around the world. Our Cloud services are helping businesses, big and small, acceleratetheir digital transformations.\"</p><p>Ruth Porat, CFO of Google and Alphabet, said: “Total revenues of $55.3 billion in the first quarter reflect elevatedconsumer activity online and broad based growth in advertiser revenue. We’re very pleased with the ongoing momentum in Google Cloud, with revenues of $4.0 billion in the quarter reflecting strength and opportunity in bothGCP and Workspace.” <b>Share Buyback Announced:</b> Along with its first-quarter earnings, Alphabet reported a $50-billion share buyback was authorized by the company. The share repurchases will be executed “from time to time.\"</p><p><b>Price Action: </b>Shares of GOOG are up 4% to $2,410 in after-hours Tuesday.</p><p><img src=\"https://static.tigerbbs.com/1cf14e52744d9520c6eea9cf5fd08aa1\" tg-width=\"1484\" tg-height=\"974\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google Shares Rise On Revenue And Earnings Beat, $50B Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle Shares Rise On Revenue And Earnings Beat, $50B Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-28 04:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Google parent company <b>Alphabet Inc </b>(NASDAQ:GOOG)(NASDAQ:GOOGL) reported first-quarter earnings Tuesday afternoon.</p><p><b>First Quarter Earnings: </b>Alphabet reported revenue of $55.3 billion in the first quarter, beating estimates of $51.7 billion. The total was up 32% year-over-year.</p><p>Earnings per share of $26.29 beat estimates of $15.88. The company reported net income of $17.9 billion, more than doubling last year’s first-quarter total of $6.8 billion.<img src=\"https://static.tigerbbs.com/04c18e5c94d3b6d4047c6f7b1f4540eb\" tg-width=\"1602\" tg-height=\"670\" referrerpolicy=\"no-referrer\">Total advertising revenue was $44.7 billion in the first quarter, up from the comparable $33.8 billion in the last fiscal year. The company reported search revenue of $31.9 billion, YouTube revenue of $6 billion and Google network revenue of $6.8 billion.</p><p>Google's Cloud revenue improved 46% to $4 billion, though the division lags behind rivals Amazon.com Inc.</p><p>The company’s other segment revenue was $6.5 billion and Google Cloud revenue was $4 billion in the first quarter.<img src=\"https://static.tigerbbs.com/9ed7cd2419e150521d3b20d080a0ba44\" tg-width=\"1614\" tg-height=\"742\" referrerpolicy=\"no-referrer\">Sundar Pichai, CEO of Google and Alphabet, said: “Over the last year, people have turned to Google Search andmany online services to stay informed, connected and entertained. We’ve continued our focus on delivering trustedservices to help people around the world. Our Cloud services are helping businesses, big and small, acceleratetheir digital transformations.\"</p><p>Ruth Porat, CFO of Google and Alphabet, said: “Total revenues of $55.3 billion in the first quarter reflect elevatedconsumer activity online and broad based growth in advertiser revenue. We’re very pleased with the ongoing momentum in Google Cloud, with revenues of $4.0 billion in the quarter reflecting strength and opportunity in bothGCP and Workspace.” <b>Share Buyback Announced:</b> Along with its first-quarter earnings, Alphabet reported a $50-billion share buyback was authorized by the company. The share repurchases will be executed “from time to time.\"</p><p><b>Price Action: </b>Shares of GOOG are up 4% to $2,410 in after-hours Tuesday.</p><p><img src=\"https://static.tigerbbs.com/1cf14e52744d9520c6eea9cf5fd08aa1\" tg-width=\"1484\" tg-height=\"974\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","GOOGL":"谷歌A"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2130373930","content_text":"Google parent company Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) reported first-quarter earnings Tuesday afternoon.First Quarter Earnings: Alphabet reported revenue of $55.3 billion in the first quarter, beating estimates of $51.7 billion. The total was up 32% year-over-year.Earnings per share of $26.29 beat estimates of $15.88. The company reported net income of $17.9 billion, more than doubling last year’s first-quarter total of $6.8 billion.Total advertising revenue was $44.7 billion in the first quarter, up from the comparable $33.8 billion in the last fiscal year. The company reported search revenue of $31.9 billion, YouTube revenue of $6 billion and Google network revenue of $6.8 billion.Google's Cloud revenue improved 46% to $4 billion, though the division lags behind rivals Amazon.com Inc.The company’s other segment revenue was $6.5 billion and Google Cloud revenue was $4 billion in the first quarter.Sundar Pichai, CEO of Google and Alphabet, said: “Over the last year, people have turned to Google Search andmany online services to stay informed, connected and entertained. We’ve continued our focus on delivering trustedservices to help people around the world. Our Cloud services are helping businesses, big and small, acceleratetheir digital transformations.\"Ruth Porat, CFO of Google and Alphabet, said: “Total revenues of $55.3 billion in the first quarter reflect elevatedconsumer activity online and broad based growth in advertiser revenue. We’re very pleased with the ongoing momentum in Google Cloud, with revenues of $4.0 billion in the quarter reflecting strength and opportunity in bothGCP and Workspace.” Share Buyback Announced: Along with its first-quarter earnings, Alphabet reported a $50-billion share buyback was authorized by the company. The share repurchases will be executed “from time to time.\"Price Action: Shares of GOOG are up 4% to $2,410 in after-hours Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377757890,"gmtCreate":1619567199910,"gmtModify":1634211783887,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Pls comment & like","listText":"Pls comment & like","text":"Pls comment & like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/377757890","repostId":"2130373930","repostType":4,"repost":{"id":"2130373930","kind":"highlight","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619556617,"share":"https://www.laohu8.com/m/news/2130373930?lang=&edition=full","pubTime":"2021-04-28 04:50","market":"hk","language":"en","title":"Google Shares Rise On Revenue And Earnings Beat, $50B Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2130373930","media":"Tiger Newspress","summary":"Google parent company Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL) reported first-quarter earnings Tuesday afternoon.","content":"<p>Google parent company <b>Alphabet Inc </b>(NASDAQ:GOOG)(NASDAQ:GOOGL) reported first-quarter earnings Tuesday afternoon.</p><p><b>First Quarter Earnings: </b>Alphabet reported revenue of $55.3 billion in the first quarter, beating estimates of $51.7 billion. The total was up 32% year-over-year.</p><p>Earnings per share of $26.29 beat estimates of $15.88. The company reported net income of $17.9 billion, more than doubling last year’s first-quarter total of $6.8 billion.<img src=\"https://static.tigerbbs.com/04c18e5c94d3b6d4047c6f7b1f4540eb\" tg-width=\"1602\" tg-height=\"670\" referrerpolicy=\"no-referrer\">Total advertising revenue was $44.7 billion in the first quarter, up from the comparable $33.8 billion in the last fiscal year. The company reported search revenue of $31.9 billion, YouTube revenue of $6 billion and Google network revenue of $6.8 billion.</p><p>Google's Cloud revenue improved 46% to $4 billion, though the division lags behind rivals Amazon.com Inc.</p><p>The company’s other segment revenue was $6.5 billion and Google Cloud revenue was $4 billion in the first quarter.<img src=\"https://static.tigerbbs.com/9ed7cd2419e150521d3b20d080a0ba44\" tg-width=\"1614\" tg-height=\"742\" referrerpolicy=\"no-referrer\">Sundar Pichai, CEO of Google and Alphabet, said: “Over the last year, people have turned to Google Search andmany online services to stay informed, connected and entertained. We’ve continued our focus on delivering trustedservices to help people around the world. Our Cloud services are helping businesses, big and small, acceleratetheir digital transformations.\"</p><p>Ruth Porat, CFO of Google and Alphabet, said: “Total revenues of $55.3 billion in the first quarter reflect elevatedconsumer activity online and broad based growth in advertiser revenue. We’re very pleased with the ongoing momentum in Google Cloud, with revenues of $4.0 billion in the quarter reflecting strength and opportunity in bothGCP and Workspace.” <b>Share Buyback Announced:</b> Along with its first-quarter earnings, Alphabet reported a $50-billion share buyback was authorized by the company. The share repurchases will be executed “from time to time.\"</p><p><b>Price Action: </b>Shares of GOOG are up 4% to $2,410 in after-hours Tuesday.</p><p><img src=\"https://static.tigerbbs.com/1cf14e52744d9520c6eea9cf5fd08aa1\" tg-width=\"1484\" tg-height=\"974\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google Shares Rise On Revenue And Earnings Beat, $50B Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle Shares Rise On Revenue And Earnings Beat, $50B Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-28 04:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Google parent company <b>Alphabet Inc </b>(NASDAQ:GOOG)(NASDAQ:GOOGL) reported first-quarter earnings Tuesday afternoon.</p><p><b>First Quarter Earnings: </b>Alphabet reported revenue of $55.3 billion in the first quarter, beating estimates of $51.7 billion. The total was up 32% year-over-year.</p><p>Earnings per share of $26.29 beat estimates of $15.88. The company reported net income of $17.9 billion, more than doubling last year’s first-quarter total of $6.8 billion.<img src=\"https://static.tigerbbs.com/04c18e5c94d3b6d4047c6f7b1f4540eb\" tg-width=\"1602\" tg-height=\"670\" referrerpolicy=\"no-referrer\">Total advertising revenue was $44.7 billion in the first quarter, up from the comparable $33.8 billion in the last fiscal year. The company reported search revenue of $31.9 billion, YouTube revenue of $6 billion and Google network revenue of $6.8 billion.</p><p>Google's Cloud revenue improved 46% to $4 billion, though the division lags behind rivals Amazon.com Inc.</p><p>The company’s other segment revenue was $6.5 billion and Google Cloud revenue was $4 billion in the first quarter.<img src=\"https://static.tigerbbs.com/9ed7cd2419e150521d3b20d080a0ba44\" tg-width=\"1614\" tg-height=\"742\" referrerpolicy=\"no-referrer\">Sundar Pichai, CEO of Google and Alphabet, said: “Over the last year, people have turned to Google Search andmany online services to stay informed, connected and entertained. We’ve continued our focus on delivering trustedservices to help people around the world. Our Cloud services are helping businesses, big and small, acceleratetheir digital transformations.\"</p><p>Ruth Porat, CFO of Google and Alphabet, said: “Total revenues of $55.3 billion in the first quarter reflect elevatedconsumer activity online and broad based growth in advertiser revenue. We’re very pleased with the ongoing momentum in Google Cloud, with revenues of $4.0 billion in the quarter reflecting strength and opportunity in bothGCP and Workspace.” <b>Share Buyback Announced:</b> Along with its first-quarter earnings, Alphabet reported a $50-billion share buyback was authorized by the company. The share repurchases will be executed “from time to time.\"</p><p><b>Price Action: </b>Shares of GOOG are up 4% to $2,410 in after-hours Tuesday.</p><p><img src=\"https://static.tigerbbs.com/1cf14e52744d9520c6eea9cf5fd08aa1\" tg-width=\"1484\" tg-height=\"974\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","GOOGL":"谷歌A"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2130373930","content_text":"Google parent company Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) reported first-quarter earnings Tuesday afternoon.First Quarter Earnings: Alphabet reported revenue of $55.3 billion in the first quarter, beating estimates of $51.7 billion. The total was up 32% year-over-year.Earnings per share of $26.29 beat estimates of $15.88. The company reported net income of $17.9 billion, more than doubling last year’s first-quarter total of $6.8 billion.Total advertising revenue was $44.7 billion in the first quarter, up from the comparable $33.8 billion in the last fiscal year. The company reported search revenue of $31.9 billion, YouTube revenue of $6 billion and Google network revenue of $6.8 billion.Google's Cloud revenue improved 46% to $4 billion, though the division lags behind rivals Amazon.com Inc.The company’s other segment revenue was $6.5 billion and Google Cloud revenue was $4 billion in the first quarter.Sundar Pichai, CEO of Google and Alphabet, said: “Over the last year, people have turned to Google Search andmany online services to stay informed, connected and entertained. We’ve continued our focus on delivering trustedservices to help people around the world. Our Cloud services are helping businesses, big and small, acceleratetheir digital transformations.\"Ruth Porat, CFO of Google and Alphabet, said: “Total revenues of $55.3 billion in the first quarter reflect elevatedconsumer activity online and broad based growth in advertiser revenue. We’re very pleased with the ongoing momentum in Google Cloud, with revenues of $4.0 billion in the quarter reflecting strength and opportunity in bothGCP and Workspace.” Share Buyback Announced: Along with its first-quarter earnings, Alphabet reported a $50-billion share buyback was authorized by the company. The share repurchases will be executed “from time to time.\"Price Action: Shares of GOOG are up 4% to $2,410 in after-hours Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374138177,"gmtCreate":1619426946299,"gmtModify":1634273581386,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Pls comment and like me","listText":"Pls comment and like me","text":"Pls comment and like me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/374138177","repostId":"1184404050","repostType":4,"isVote":1,"tweetType":1,"viewCount":575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374932816,"gmtCreate":1619407667735,"gmtModify":1634273713439,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Pls like and comment me","listText":"Pls like and comment me","text":"Pls like and comment me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/374932816","repostId":"1117221855","repostType":4,"isVote":1,"tweetType":1,"viewCount":586,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":375895252,"gmtCreate":1619321108276,"gmtModify":1634274256291,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Ok ","listText":"Ok ","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/375895252","repostId":"1140669469","repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://www.laohu8.com/m/news/1140669469?lang=&edition=full","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b> (NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8 <a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"tweetType":1,"viewCount":639,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":375892558,"gmtCreate":1619321063374,"gmtModify":1634274257016,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Hi ","listText":"Hi ","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/375892558","repostId":"1140669469","repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://www.laohu8.com/m/news/1140669469?lang=&edition=full","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b> (NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8 <a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"tweetType":1,"viewCount":660,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":375896723,"gmtCreate":1619321030262,"gmtModify":1634274257621,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582013492527536","authorIdStr":"3582013492527536"},"themes":[],"htmlText":"Pls like & give me comment ","listText":"Pls like & give me comment ","text":"Pls like & give me comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/375896723","repostId":"1140669469","repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://www.laohu8.com/m/news/1140669469?lang=&edition=full","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b> (NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8 <a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}